Ticker

BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) held the general meeting on March 12, 2026 and approved the previously announced business combination (the “Business Combination”) with VERAXA Biotech AG (“VERAXA”). After the closing of the Business Combination, it is expected that the combined company will trade on…

BROOKLYN, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) today announced that holders of 25,217,315 of the Company's Class A ordinary shares (“Class A shares”) exercised their right to redeem their shares for a pro rata portion of the funds in the Company's trust account, reflecting redemptions of approximately 99.67% of the…

Crossingbridge Advisors LLC acquired a new position in shares of Voyager Acquisition Corp. (NASDAQ: VACH) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 46,779 shares of the company's stock, valued at approximately $490,000. Crossingbridge Advisors LLC owned approximately

VERAXA shareholders approve merger & issuance of new shares to Voyager. Both resolutions are prerequisites for the closing of the business combination.